IP Library Assignment 075763/0709
Patent Assignment
Reel/Frame 075763/0709

Assignment of Assignor's Interest

Recorded: 2026-08-25 Pages: 10
Assignor
CUMBERLAND PHARMACEUTICALS INC.
Executed: 2026-06-30
Assignee
APOTEX CORP.
150 SIGNET DRIVE, TORONTO, ONTARIO, M9L1T9, CANADA
Covered Properties (20)
Injectable Ibuprofen Formulation
Application: 19/027,478 →
Publication: US US20250235539A1
Methods for the Prevention or Treatment of Anthrax Infection
Application: 19/560,105 →
Publication: US US20260199427A1
Methods for the Prevention or Treatment of Anthrax Infection
Application: 17/992,470 →
Publication: US US20240024411A1
Acetylcysteine Composition and Uses Therefor
Patent: 8,148,356 →
Application: 11/209,804 →
Publication: US US20070049640A1
Acetycysteine Compositions and Methods of Use Thereof
Patent: 8,722,738 →
Application: 13/188,152 →
Publication: US US20120022161A1
Acetylcysteine Compositions and Methods of use Thereof
Patent: 9,327,028 →
Application: 14/225,345 →
Publication: US US20140206765A1
Administration of Intravenous Ibuprofen
Patent: 9,012,508 →
Application: 12/722,682 →
Publication: US US20100234465A1
Treating Patients with Intravenous Ibuprofen
Patent: 8,735,452 →
Application: 12/699,595 →
Publication: US US20110028557A1
Treating Critically Ill Patients with Intravenous Ibuprofen
Patent: 9,295,639 →
Application: 12/830,991 →
Publication: US US20110028558A1
Treating Critically Ill Patients with Intravenous Ibuprofen
Patent: 8,871,810 →
Application: 12/646,499 →
Publication: US US20110028553A1
Treating Patients with Intravenous Ibuprofen
Patent: 9,114,068 →
Application: 14/264,267 →
Publication: US US20140235720A1
Treating Critically Ill Patients with Intravenous Ibuprofen
Patent: 9,138,404 →
Application: 14/507,331 →
Publication: US US20150087710A1
Treating Critically Ill Patients with Intravenous Ibuprofen
Patent: 9,649,284 →
Application: 14/825,803 →
Publication: US US20160113894A1
Treating Critically Ill Patients with Intravenous Ibuprofen
Patent: 9,931,311 →
Application: 15/484,349 →
Publication: US US20170216232A1
Injectable Ibuprofen Formulation
Patent: 9,072,710 →
Application: 13/422,761 →
Publication: US US20130245120A1
Injectable Ibuprofen Formulation
Patent: 9,072,661 →
Application: 13/422,738 →
Publication: US US20130245591A1
Injectable Ibuprofen Formulation
Application: 16/869,277 →
Publication: US US20200261581A1
Hydrochloride Salts of a Glycopeptide Phosphonate Derivative
Patent: 7,531,623 →
Application: 10/970,128 →
Publication: US US20050113561A1
Hydrochloride Salts of a Glycopeptide Phosphonate Derivative
Patent: 8,003,755 →
Application: 12/082,096 →
Publication: US US20090069534A1
Doses and Methods for Administering Telavancin
Application: 15/945,126 →
Publication: US US20180236027A1
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 21, 2004
From: LIU, JYANWEI; LEE, JUNNING
To: THERAVANCE, INC.
Reel/Frame 015919/0019 →
Assignment of Assignor's Interest Aug 24, 2005
From: PAVLIV, LEO
To: CUMBERLAND PHARMACEUTICALS, INC.
Reel/Frame 016921/0887 →
Security Agreement Jan 13, 2009
From: CUMBERLAND PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 022100/0590 →
Security Interest Jul 24, 2009
From: CUMBERLAND PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 023015/0807 →
Assignment of Assignor's Interest Oct 15, 2009
From: LIU, JYANWEI; LEE, JUNNING
To: THERAVANCE, INC.
Reel/Frame 023379/0467 →
Assignment of Assignor's Interest Oct 15, 2009
From: LIU, JYANWEI; LEE, JUNNING
To: THERAVANCE, INC.
Reel/Frame 023379/0463 →
Assignment of Assignor's Interest Mar 12, 2010
From: PAVLIV, LEO; ROCK, AMY DIX
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 024076/0233 →
Assignment of Assignor's Interest Mar 12, 2010
From: PAVLIV, LEO
To: CUMBERLAND PHARMACEUTICALS
Reel/Frame 024078/0293 →
Assignment of Assignor's Interest May 25, 2010
From: PAVLIV, LEO; ROCK, AMY DIX
To: CUMBERLAND PHARMACEUTICALS, INC.
Reel/Frame 024439/0840 →
Security Agreement Oct 8, 2010
From: CUMBERLAND PHARMACEUTICALS, INC,
To: BANK OF AMERICA, N.A.
Reel/Frame 025105/0979 →
Assignment of Assignor's Interest Oct 10, 2012
From: PAVLIV, LEO; VILA, ANDREW
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 029102/0816 →
Assignment of Assignor's Interest Oct 10, 2012
From: PAVLIV, LEO; VILA, ANDREW
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 029102/0855 →
Assignment of Assignor's Interest Feb 25, 2014
From: PAVLIV, LEO; ROCK, AMY
To: CUMBERLAND PHARMACEUTICALS, INC.
Reel/Frame 032295/0521 →
Assignment of Assignor's Interest Apr 18, 2014
From: PAVLIV, LEO; ROCK, AMY
To: CUMBERLAND PHARMACEUTICALS, INC.
Reel/Frame 032706/0947 →
Assignment of Assignor's Interest May 7, 2014
From: PAVLIV, LEO; ROCK, AMY DIX
To: CUMBERLAND PHARMACEUTICALS, INC.
Reel/Frame 032838/0718 →
Assignment of Assignor's Interest Jun 12, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033180/0571 →
Assignment of Assignor's Interest Jan 20, 2015
From: PAVLIV, LEO, MR; ROCK, AMY DIX, DR
To: CUMBERLAND PHARMACEUTICALS INC
Reel/Frame 034751/0446 →
Assignment of Assignor's Interest Oct 16, 2015
From: PAVLIV, LEO; ROCK, AMY DIX
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 036807/0636 →
Assignment of Assignor's Interest Feb 22, 2018
From: PAVLIV, LEO; ROCK, AMY DIX
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 045415/0087 →
Assignment of Assignor's Interest Dec 14, 2018
From: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 047909/0853 →
Assignment of Assignor's Interest May 7, 2020
From: PAVLIV, LEO; VILA, ANDREW
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 052617/0114 →
Assignment of Assignor's Interest Dec 10, 2022
From: PAVLIV, LEO; MACIAS-PEREZ, INES
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 062047/0827 →
Assignment of Assignor's Interest Jan 17, 2025
From: PAVLIV, LEO; VILA, ANDREW
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 069941/0322 →
Corrective Assignment to Correct the "Inc." Inadvertently Omitted After Name of Receiving Party "Cumberland Pharmaceuticals" Previously Recorded on Reel 24078 Frame 294. Assignor(S) Hereby Confirms the Assignment. Apr 9, 2026
From: PAVLIV, LEO
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 075506/0995 →